Retinoid Hyperostosis
- 28 April 1983
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 308 (17) , 1012-1014
- https://doi.org/10.1056/nejm198304283081707
Abstract
An oral synthetic vitamin A derivative, 13-cis-retinoic acid (isotretinoin), is effective in controlling a wide variety of dermatoses. Short-term use produces sustained remission in severe refractory cystic and conglobate acne.1 Higher doses and long-term administration are required to control keratinizing dermatoses, such as lamellar ichthyosis.2 In four of nine consecutive patients receiving long-term 13-cis-retinoic acid for ichthyosis, we have observed an ossification disorder resembling diffuse idiopathic skeletal hyperostosis.Case 1Two years after beginning to take 13-cis-retinoic acid (3 mg per kilogram of body weight per day) for lamellar ichthyosis, a 33-year-old woman had . . .Keywords
This publication has 9 references indexed in Scilit:
- Oral RetinoidsArchives of Dermatology, 1981
- Retinoids, Cancer, and the SkinArchives of Dermatology, 1981
- Inhibition by Retinoic Acid of Collagenase Production in Rheumatoid Synovial CellsNew England Journal of Medicine, 1980
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979
- Ankylosing Hyperostosis of the SpineClinical Orthopaedics and Related Research, 1971
- Hypervitaminosis A and Hyperostosis of the CatNature, 1965
- Vitamin A poisoning in adults: With description of a caseThe American Journal of Medicine, 1954